🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

PLUR PLUR

Company Profile ↓
$1.74
-67.54% 1Y
Mkt Cap$13.74M
P/E-0.49
P/B-2.01
52W High$5.68
52W Low$1.55
Book Value$-0.87
EPS (TTM)$-3.56

Company Overview

PLUR (PLUR) is a publicly traded company listed on with a market capitalization of $13.74M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Recent Developments

  • Jun 2025 Revenue of $1.34M (+309.8% YoY); net profit $-22.58M.
  • Trailing 12 Months Year-on-year growth — revenue +309.8%.
  • 5-Year Trend Long-term compounding — revenue CAGR 5.8%.

Growth & Price Performance

Compounded Sales Growth

5 Years:5.83%
1 Year:309.82%

Stock Price Performance

1 Year:-67.54%
6 Months:-50.14%
3 Months:-47.27%
1 Month:-15.94%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 5% of range
$1.55 $5.68
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)45.65 · Neutral
Price Performance
1M-15.94%
3M-47.27%
6M-50.14%
1Y-67.54%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Trading 69.4% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.49
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-0.87
Price to Book
-2.01
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
5.83%
Profit 5Y
-
Revenue (YoY)
309.82%
Earnings (YoY)
-

Profitability & Returns

ROCE
-
ROE
-
ROA
-58.38%
Profit Margin
-
Op Margin
-
Gross Margin
48.95%
EPS (Latest Qtr)
$-0.55
EPS (TTM)
$-3.56

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
0.68
Debt
$34.05M
Total Assets
$26.06M
Current Assets
$10.46M
Working Capital
$-10.23M

Ownership

Promoter Holding
46.57%
Chg in Prom Hold
-
FII / Inst Holding
12.55%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$1.34M
EBITDA
$-22.07M
Free Cash Flow
$-19.83M
Operating Cash Flow
$-18.21M
Shares Outstanding
7.89M
Gross Margin
48.95%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2013Dec 2013Mar 2014Sep 2014Dec 2014Mar 2015Sep 2015Dec 2015Mar 2016Sep 2016Dec 2016Mar 2017Sep 2017Dec 2017Mar 2018Sep 2018Dec 2018Mar 2019Sep 2019Dec 2019Mar 2020Sep 2020Dec 2020Mar 2021Sep 2021Dec 2021Mar 2022Sep 2022Dec 2022Mar 2023Sep 2023Dec 2023Mar 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 95.00K95.00K95.00K95.00K95.00K95.00K95.00K2.75M-----50.00K-4.00K50.00K--23.00K------234.00K87.00K2.00K87.00K54.00K105.00K71.00K326.00K-427.00K398.00K316.00K198.00K167.00K
Cost of Revenue -----------------------------------291.00K191.00K201.00K112.00K111.00K
Gross Profit 92.00K92.00K92.00K92.00K91.00K92.00K92.00K2.65M-----48.00K-4.00K48.00K--22.00K----------54.00K105.00K71.00K200.00K-136.00K207.00K115.00K86.00K56.00K
Operating Expenses -----------------------------------5.54M6.83M6.46M6.59M6.59M
Operating Income -4.86M-6.99M-9.29M-5.62M-6.30M-7.53M-5.52M-4.23M-7.39M-6.56M-6.65M-8.22M-7.44M-8.47M-9.05M-8.97M-8.33M-10.30M-7.20M-6.37M-7.40M-8.74M-13.07M-14.22M-11.44M-10.79M-10.47M-6.92M-6.68M-7.10M-5.38M-5.21M-5.53M-5.20M--5.40M-6.62M-6.35M-6.51M-6.54M
EBITDA ------------------------------------6.05M-7.43M-5.78M-6.52M-5.82M
Interest Expense -----------------------------------212.00K233.00K229.00K231.00K237.00K
Pretax Income ------------------------------------6.33M-7.77M-6.14M-6.88M-6.18M
Tax Provision -----------------------------------0--8.00K-8.00K-8.00K
Net Income -4.75M-6.71M-9.28M-5.91M-6.25M-7.23M-5.88M-3.96M-7.20M-6.32M-6.61M-7.86M-7.38M-8.23M-1.53M-8.79M-8.68M-10.08M-7.14M-6.37M-7.51M-8.49M-12.55M-14.25M-11.43M-10.94M-9.87M-6.12M-8.12M-7.62M-4.96M-4.91M-5.29M-5.88M--6.15M-7.60M-5.85M-6.54M-5.55M
Diluted EPS -------------------------0.36-0.34-0.31-0.19-0.24-1.52-0.96-0.96-1.01-1.08-0.53-0.94--0.65-0.71-0.55
R&D Expense 5.50M6.11M6.88M5.74M5.38M6.18M5.06M5.57M5.80M6.03M5.48M6.58M5.19M6.26M7.48M7.76M7.43M8.42M5.83M5.57M5.74M6.20M8.00M7.82M6.39M6.54M6.27M4.50M3.79M4.17M2.99M2.96M3.09M2.89M2.92M3.04M-3.93M3.83M3.96M

Profit & Loss (Annual)

Figures in USD.

Metric Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Revenue --716.00K679.00K379.00K379.00K2.85M-50.00K54.00K23.00K-234.00K287.00K326.00K1.34M
Cost of Revenue ------------09.00K4.00K682.00K
Gross Profit --695.00K659.00K368.00K366.00K2.75M-48.00K52.00K23.00K-234.00K278.00K322.00K654.00K
Operating Expenses ------------41.83M27.52M22.48M22.83M
Operating Income -7.44M-11.11M-15.03M-22.22M-27.85M-25.27M-23.32M-28.02M-33.73M-35.53M-29.48M-50.62M-41.59M-27.25M-22.16M-22.18M
EBITDA -------------39.43M-27.68M-20.23M-22.07M
Interest Expense ------------887.00K843.00K866.00K873.00K
Pretax Income -------------41.37M-28.89M-21.34M-23.25M
Tax Provision --------------0-5.00K
Net Income -7.45M-10.85M-14.79M-21.16M-26.93M-24.68M-23.25M-27.81M-26.13M-35.31M-29.15M-49.87M-41.24M-28.32M-20.89M-22.58M
Diluted EPS ------------1.77-10.24-6.24-3.99-3.56
R&D Expense 6.12M8.31M12.69M19.91M24.94M23.42M22.86M24.00M26.37M29.88M23.10M30.53M24.61M15.74M12.45M12.85M

Balance Sheet (Annual)

Figures in USD.

Metric Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Total Assets --46.02M47.42M68.32M74.02M68.16M45.94M37.53M38.96M31.31M65.53M93.54M68.06M50.80M39.53M38.68M
Current Assets -------------57.75M41.41M31.11M22.09M
Cash & Equivalents 2.34M1.58M42.83M9.39M9.01M4.49M22.63M6.22M4.71M8.82M4.11M8.27M31.24M9.77M5.36M6.78M5.89M
Inventory -----------------
Receivables -------------955.00K360.00K501.00K424.00K
Total Liabilities -------------35.88M35.50M34.11M39.55M
Current Liabilities --2.02M5.52M5.92M7.40M6.18M5.78M5.41M8.55M8.16M7.99M11.52M6.83M5.62M4.45M32.33M
Long Term Debt -------------21.68M23.53M24.03M-
Total Debt -------------28.80M29.91M29.61M34.05M
Total Equity 3.39M3.98M43.42M37.74M57.47M62.12M58.14M38.16M30.25M28.51M21.82M56.10M57.15M30.04M13.36M96.00K-6.84M
Shares Outstanding -------------4.06M5.16M5.41M7.89M

Cash Flows (Annual)

Figures in USD.

Metric Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Operating Cash Flow -5.41M-5.75M-3.27M-16.89M--20.61M-18.52M-21.61M-21.38M-29.45M-26.37M-30.91M-36.50M-22.86M-18.02M-18.21M
Investing Cash Flow -1.30M-36.00K-30.80M-19.80M-21.54M1.31M4.36M5.68M1.17M-30.46M-7.26M11.78M9.70M10.58M8.03M
Financing Cash Flow 5.95M47.04M632.00K36.30M-17.20M807.00K15.80M19.92M23.58M60.87M61.40M7.50M8.02M8.84M9.53M
Capital Expenditure -389.00K-962.00K-1.48M-4.31M-1.57M-831.00K-1.75M-378.00K-342.00K-239.00K-270.00K-373.00K-280.00K-262.00K-323.00K-1.62M
Free Cash Flow -5.80M-6.72M-4.75M-21.20M--21.44M-20.27M-21.99M-21.72M-29.69M-26.64M-31.28M-36.78M-23.12M-18.34M-19.83M
Net Change in Cash -------------17.22M-5.13M1.40M-652.00K

Ratios (Annual)

Figures in %.

Metric Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Gross Margin % --97.1%97.1%97.1%96.6%96.5%-96.0%96.3%100.0%-100.0%96.9%98.8%49.0%
Operating Margin % ---2,099.3%-3,272.9%-7,348.3%-6,666.8%-819.1%--67,462.0%-65,800.0%-128,156.5%--17,774.8%-9,493.4%-6,796.9%-1,659.9%
Net Margin % ---2,066.2%-3,115.6%-7,106.1%-6,511.1%-816.5%--52,252.0%-65,383.3%-126,747.8%--17,624.8%-9,867.9%-6,407.4%-1,690.3%
ROE % -187.2%-25.0%-39.2%-36.8%-43.4%-42.4%-60.9%-91.9%-91.6%-161.8%-52.0%-87.3%-137.3%-212.1%-21,758.3%330.1%
ROCE % --25.3%-35.9%-35.6%-41.8%-40.8%-58.1%-87.2%-110.9%-153.5%-51.2%-61.7%-67.9%-60.3%-63.2%-349.0%

Shareholding Pattern

Insiders
46.57%
Institutions
12.55%
Public Float
23.50%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for PLUR

Yahoo Finance ue, 28 Jul 2026

Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK

UK regulatory registration supports commercial launch of regenerative aesthetics portfolio in a market with an estimated size of ~$900 million annually, and strengthens the foundation for broader international expansion HAIFA, Israel, July …

Yahoo Finance ue, 14 Jul 2026

Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30%

Through a series of investments over the past year, including an additional investment made in June 2026, Weinstein has built an ownership position of more than 30% as Pluri advances its longevity and U.S. commercialization strategyHAIFA, I…

Yahoo Finance ue, 02 Jun 2026

Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing

Two regenerative aesthetic and longevity products, with clinically validated ingredients, are expected to reach the U.S. market during 2026, entering a rapidly expanding U.S. medical aesthetics market, projected to reach $90 billion by 2030…

Yahoo Finance Sat, 30 May 2026

Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest In

We just covered the 7 Best Lab-Grown Meat Stocks to Invest In and Pluri Inc. (NASDAQ:PLUR) ranks 4th on this list. Pluri Inc. (NASDAQ:PLUR), through the highly publicized joint venture, Ever After Foods, utilizes proprietary, state-of-the-a…

Yahoo Finance hu, 28 May 2026

Pluri Insider Ups Holding During Year

Insiders were net buyers of Pluri Inc.'s ( NASDAQ:PLUR ) stock during the past year. That is, insiders bought more...

Yahoo Finance Fri, 01 May 2026

EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug

NewcelX Ltd. reported its 2025 financial results, with leadership emphasizing a "transformative year" marked by merger completion, balance sheet improvements, and progress in its lead Type 1 diabetes program, NCEL-101. Ronen Twito, executiv…

PLUR — Frequently Asked Questions

What is the current share price of PLUR?

As of 2026-08-05 17:25 PDT, PLUR trades at $1.74 on NASDAQ/NYSE. Its 52-week range is $1.55 to $5.68.

What is the market capitalisation of PLUR?

PLUR has a market capitalisation of $13.74M on NASDAQ/NYSE.

What is the P/E ratio of PLUR?

PLUR trades at a trailing price-to-earnings (P/E) ratio of -0.49. Its price-to-book (P/B) ratio is -2.01.

Is PLUR a good stock to buy?

This page provides a data-driven analysis of PLUR, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space